[vc_row][vc_column][rev_slider_vc alias=”gennova_sliders”][vc_single_image image=”12547″ img_size=”1178×220″ alignment=”center” css_animation=”fadeIn”][/vc_column][/vc_row][vc_row expanded=”2″ css=”.vc_custom_1578579517192{background-color: #f1f1f1 !important;}”][vc_column][vc_row_inner][vc_column_inner][vc_empty_space height=”80px”][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner width=”7/12″][section_header main_heading=”Transforming Healthcare” text_align=”left” font_size=”custom” custom_font_size=”30″ font_weight=”bold” use_multi_color=”0″][vc_empty_space height=”20px”][section_header main_heading=”One of our greatest assets is our appreciation and understanding of the complexity of a problem and dedicated focus to develop a long lasting solution instead of looking for a quick fix. We realized early on that we will not be able to develop, deliver and survive in the competitive market of biotechnology if we do not innovate across all the required scientific platforms. This is what separates us from the rest of the traditional biotechnology companies interested in making biosimilar.” text_align=”left” font_size=”custom” custom_font_size=”18″ font_weight=”normal” line_height=”35px” use_multi_color=”0″ css=”.vc_custom_1586950401944{padding-right: 30px !important;}”][/vc_column_inner][vc_column_inner width=”5/12″][vc_single_image image=”10031″ img_size=”477×375″ alignment=”right” onclick=”custom_link” css=”.vc_custom_1648457270495{background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” link=”http://gennova.bio/what-how-why”][/vc_column_inner][/vc_row_inner][vc_empty_space height=”80px”][/vc_column][/vc_row][vc_section content_placement=”top” css=”.vc_custom_1578586442462{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: #072339 !important;}”][vc_row expanded=”2″ css=”.vc_custom_1578585378866{background-color: #072339 !important;}”][vc_column][vc_empty_space height=”40px”][section_header main_heading=”Company Highlights” font_size=”custom” custom_font_size=”35px” font_weight=”700″ use_multi_color=”0″ color=”#ffffff”][vc_empty_space height=”40px”][/vc_column][/vc_row][vc_row expanded=”2″ css=”.vc_custom_1578585564511{background-color: #072339 !important;}”][vc_column width=”1/3″][vc_row_inner content_placement=”top”][vc_column_inner][vc_column_text el_class=”wt”] Gene to Market [/vc_column_text][vc_column_text css=”.vc_custom_1719638142631{margin-left: 70px !important;}” el_class=”wt”]

• 9 Commercialized
  Bio-therapeutics
• 3 products – market leader in India
• 2 novel products

[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″][vc_row_inner content_placement=”top”][vc_column_inner][vc_column_text el_class=”wt”] Platform Technology[/vc_column_text][vc_column_text css=”.vc_custom_1708505882231{margin-left: 70px !important;}” el_class=”wt”]

• Patented manufacturing process
• Readily scalable
• AI guided innovation in
  Bio-manufacturing

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_empty_space height=”40px”][/vc_column][vc_column width=”1/3″][vc_column_text el_class=”wt”] Potential[/vc_column_text][vc_column_text css=”.vc_custom_1708505587728{margin-left: 70px !important;}” el_class=”wt”]

• 2 patents with market exclusivity
• Unmet market need
• Facility under development as per USFDA norms
• Global clinical trials for 3 products in next 12-18 months
• Quick launch in global market

[/vc_column_text][/vc_column][/vc_row][vc_row expanded=”2″ css=”.vc_custom_1588926439805{background-color: #072339 !important;}”][vc_column width=”1/3″][vc_row_inner content_placement=”top”][vc_column_inner][vc_column_text el_class=”wt”] Team[/vc_column_text][vc_column_text css=”.vc_custom_1708505618178{margin-left: 70px !important;}” el_class=”wt”]

• A strong leadership team, experienced in successful global collaboration and taking product from lab to market

[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″][vc_column_text el_class=”wt”] Pipeline[/vc_column_text][vc_column_text css=”.vc_custom_1708505650446{margin-left: 70px !important;}” el_class=”wt”]

• Biologics
• Vaccines
• Next-Gen therapeutics

[/vc_column_text][/vc_column][vc_column width=”1/3″][vc_row_inner content_placement=”top”][vc_column_inner][vc_column_text el_class=”wt”][/vc_column_text][vc_column_text css=”.vc_custom_1708505819396{margin-left: 70px !important;}” el_class=”wt”][/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row expanded=”2″ css=”.vc_custom_1578585864985{background-color: #072339 !important;}”][vc_column][vc_empty_space height=”40px”][/vc_column][/vc_row][/vc_section][vc_row expanded=”2″ css=”.vc_custom_1578579517192{background-color: #f1f1f1 !important;}”][vc_column][/vc_column][/vc_row][vc_section content_placement=”top” css=”.vc_custom_1578911253138{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: #f1f1f1 !important;}”][vc_row expanded=”2″ css=”.vc_custom_1578911220877{background-color: #f1f1f1 !important;}”][vc_column][vc_row_inner][vc_column_inner][section_header main_heading=”Milestones” font_size=”custom” custom_font_size=”35px” font_weight=”700″ use_multi_color=”0″][vc_empty_space height=”20px”][/vc_column_inner][/vc_row_inner][vc_empty_space height=”40px”][vc_single_image image=”12528″ img_size=”full” alignment=”center”][/vc_column][/vc_row][vc_row expanded=”2″][vc_column][vc_empty_space height=”20px”][/vc_column][/vc_row][/vc_section][vc_section content_placement=”top” css=”.vc_custom_1586446490687{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-image: url(http://localhost/gennova/wp-content/uploads/2020/01/About-Us_Banner-1920-px-x-600-px.jpg?id=10087) !important;}”][vc_row expanded=”2″][vc_column][vc_empty_space height=”80px”][/vc_column][/vc_row][vc_row expanded=”2″][vc_column width=”1/2″][vc_row_inner content_placement=”top”][vc_column_inner][section_header main_heading=”Infrastructure” text_align=”left” font_size=”custom” custom_font_size=”25px” font_weight=”bold” use_multi_color=”0″ color=”#ffffff”][vc_empty_space height=”30px”][vc_column_text]Other than our marketing strategies our investment in the technological development of the infrastructure gives us an edge over others. We have experience and expertise that allows us to develop innovative and cost effective products because of the cutting edge technology backed by research.[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/2″][vc_row_inner content_placement=”top”][vc_column_inner][section_header main_heading=”Global Collaborations” text_align=”left” font_size=”custom” custom_font_size=”25px” font_weight=”bold” use_multi_color=”0″ color=”#ffffff”][vc_empty_space height=”30px”][vc_column_text]“Many factors play an important role in the process of Transforming Healthcare, and one of the most important is that we cannot innovate in isolation. We have to have collaborations.”

– Dr. Sanjay Singh, CEO, Gennova Biopharmaceuticals Ltd.[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row expanded=”2″][vc_column][vc_empty_space height=”80px”][/vc_column][/vc_row][/vc_section][vc_section content_placement=”top” css=”.vc_custom_1578911253138{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-color: #f1f1f1 !important;}”][vc_row expanded=”2″ css=”.vc_custom_1578911220877{background-color: #f1f1f1 !important;}”][vc_column][vc_row_inner][vc_column_inner][section_header main_heading=”Gene to Market” text_align=”left” font_size=”custom” custom_font_size=”35px” font_weight=”700″ use_multi_color=”0″][vc_empty_space height=”20px”][vc_column_text]

We have a team of experienced and capable scientists and technocrats who have developed capabilities across scientific, manufacturing, regulatory, clinical and business arenas that have made it successful in the Indian market.
The experience and capabilities will facilitate the expansion of business in the global market for our current and pipeline products.

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_empty_space height=”40px”][vc_single_image image=”12645″ img_size=”large” css=””][vc_empty_space height=”20px”][/vc_column][/vc_row][vc_row expanded=”2″][vc_column][vc_empty_space height=”20px”][/vc_column][/vc_row][/vc_section]
[vc_row][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row]
[vc_row][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row]

[vc_row][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row]